StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Down 0.1 % Shares of PIRS stock opened at $10.48 on Thursday. Pieris Pharmaceuticals has a twelve month low of $10.31 and […]
Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report report published on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Down 7.2 % NASDAQ:PIRS opened at $0.24 on Friday. Pieris Pharmaceuticals has a 1-year low of $0.16 and a 1-year high […]
StockNews com Initiates Coverage on Pieris Pharmaceuticals (NASDAQ:PIRS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Rating) – Equities researchers at Jefferies Financial Group issued their FY2027 earnings per share estimates for shares of Pieris Pharmaceuticals in a research note issued to investors on Wednesday, March 29th. Jefferies Financial Group analyst R. Song anticipates that the biotechnology company will post earnings per share of ($0.38) […]